BL
Belite Bio, Inc (BLTE)
NASDAQ·Healthcare·Biotechnology
$137.96
+0.81%
Mkt Cap $6.72B
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$203.00
Range $187.00 – $223.00
Implied Upside
+47.1%
Consensus $203.00 vs current $137.96
NASDAQ·Healthcare·Biotechnology
$137.96
+0.81%
Mkt Cap $6.72B
No recent rating data.
Price Target (10 analysts)
$203.00
Range $187.00 – $223.00
+47.1%
Consensus $203.00 vs current $137.96